What is VERADIGM INC's earnings per share (EPS)?

VERADIGM INC (MDRX) reported diluted earnings per share of -$2.70 for fiscal year 2024. This represents a -758.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

VERADIGM (MDRX) Financials

MDRX OTC

FY2024 annual

Revenue $594.4M -5.0% YoY

Net Income -$291.5M -692.8% YoY

EPS (Diluted) -$2.70 -758.5% YoY

Free Cash Flow -$21.6M -122.2% YoY

Market Cap $517.7M as of Oct 27, 2026

Price / Sales 0.9x on $594.4M revenue, FY2024

Price / Earnings n/m net loss, so no earnings multiple, FY2024

Price / Book 0.6x on $804.0M equity, Q4 FY2024

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 27, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2024, ended Dec 31, 2024 Reported May 26, 2026 Currency USD FYE December

Newest figures come from the 10-K for FY2024, filed May 26, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MDRX SEC filings page.

VERADIGM INC (MDRX) reported $594.4M in revenue for fiscal year 2024, down 5.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MDRX FY2024 2026-10-25

Veradigm’s 2024 setback came less from sales collapse than from an expense structure that expanded sharply as revenue slipped.

In FY2023, net income of $49.2M became operating cash flow of $99.5M; in FY2024, a net loss of $291.5M coincided with operating cash flow of -$20.0M. That directional alignment indicates the deterioration was reflected in cash generation, rather than being solely an accounting effect.

Even with capital expenditures at just 0.3% of revenue, FY2024 free cash flow was -$21.6M; the cash shortfall therefore reflects operations, not an aggressive reinvestment program.

Revenue fell 5.0% while SG&A rose 34.1%, increasing the expense burden as sales softened. Equity fell 25.2% as assets contracted, while debt-to-equity remained 0.1x; the balance-sheet strain is therefore not explained by heavy reported debt.

Financial Health Signals

Financial health score not available

VERADIGM INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

1.06

VERADIGM INC scores 1.06, below the 1.81 distress threshold. The score is pulled down most by an operating loss of $194.7M against total assets of $1.4B. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/7

VERADIGM INC passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 operating efficiency signals passes.

Earnings Quality No Cash Backing

N/A

VERADIGM INC reported a net loss of $291.5M while operations used $20.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

VERADIGM INC reported an operating loss of $194.7M against $15.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$150.1M

YoY-2.9%

QoQ+3.4%

5Y CAGR-18.4%

10Y CAGR-7.9%

VERADIGM INC generated $150.1M in revenue in Q4 2024. This represents a decrease of 2.9% from the same quarter a year earlier. Against the prior quarter it is up 3.4%.

EBITDA

-$222K

YoY-103.2%

QoQn/m

5Y CAGRn/m

VERADIGM INC's EBITDA was -$222K in Q4 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 103.2% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income

-$113.6M

QoQn/m

VERADIGM INC reported a net loss of $113.6M in Q4 2024. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)

-$1.05

YoY-2725.0%

QoQn/m

VERADIGM INC earned -$1.05 per diluted share (EPS) in Q4 2024. This represents a decrease of 2725.0% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Free Cash Flow

-$3.0M

YoY-115.3%

QoQn/m

VERADIGM INC recorded an outflow of $3.0M in free cash flow in Q4 2024, representing a cash shortfall after capex. This represents a decrease of 115.3% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt

$294.3M

YoY-34.1%

QoQ-2.7%

5Y CAGR+17.8%

10Y CAGR+18.7%

VERADIGM INC held $294.3M in cash against $72.2M in long-term debt as of Q4 2024.

Shares Outstanding

108M

VERADIGM INC had 108M shares outstanding in Q4 2024.

Dividends Per Share

Not reported for Q4 2024.

Margins & Returns

Gross Margin

50.0%

YoY-4.2pp

QoQ+0.2pp

5Y change+13.2pp

10Y change+10.0pp

VERADIGM INC's gross margin was 50.0% in Q4 2024, indicating the percentage of revenue retained after direct costs. This is down 4.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Operating Margin

-7.6%

YoY-4.7pp

QoQ+8.3pp

5Y change+5.7pp

10Y change-7.8pp

VERADIGM INC's operating margin was -7.6% in Q4 2024, reflecting core business profitability. This is down 4.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 8.3 percentage points.

Net Margin

-75.7%

QoQ-58.9pp

VERADIGM INC's net profit margin was -75.7% in Q4 2024, showing the share of revenue converted to profit. Against the prior quarter it is down 58.9 percentage points.

Return on Equity

-14.1%

QoQ-11.4pp

VERADIGM INC's quarterly ROE was -14.1% in Q4 2024: one quarter's net income over shareholder equity, not annualized. Against the prior quarter it is down 11.4 percentage points.

Capital Allocation

R&D Spending

$26.4M

YoY+12.8%

QoQ-2.1%

5Y CAGR-15.2%

10Y CAGR-4.4%

VERADIGM INC invested $26.4M in research and development in Q4 2024. This represents an increase of 12.8% from the same quarter a year earlier. Against the prior quarter it is down 2.1%.

Capital Expenditures

$334K

YoY-6.2%

QoQ+125.7%

5Y CAGR-35.4%

10Y CAGR-24.8%

VERADIGM INC invested $334K in capex in Q4 2024, funding long-term assets and infrastructure. This represents a decrease of 6.2% from the same quarter a year earlier. Against the prior quarter it is up 125.7%.

Share Buybacks

Not reported for Q4 2024.

MDRX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MDRX quarterly income statement

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Revenue	$594.4M-5.0%	$626.0M+6.5%	$588.0M+1.8%	$577.4M+3.8%	$556.1M-65.9%	$1.6B+0.9%	$1.6B-10.4%	$1.8B+16.5%	$1.5B+11.8%	$1.4B+0.6%	$1.4B+0.4%	$1.4B-5.1%	$1.4B+0.2%	$1.4B+105.0%	$704.5M
Cost of Revenue	$292.2M+2.7%	$284.5M+1.7%	$279.6M-5.2%	$295.0M+1.1%	$291.9M-71.4%	$1.0B+2.6%	$996.5M+15.2%	$864.9M+10.2%	$784.8M-2.6%	$805.8M-3.1%	$831.9M-0.8%	$838.6M-0.1%	$839.8M+7.9%	$778.5M+146.6%	$315.7M
Gross Profit	$302.2M-11.5%	$341.5M+10.7%	$308.4M+9.2%	$282.4M+6.9%	$264.2M-56.7%	$610.3M-1.8%	$621.4M-1.8%	$632.8M+5.2%	$601.3M+3.6%	$580.6M+6.3%	$546.0M+2.2%	$534.5M-11.9%	$606.5M-8.9%	$665.6M+71.2%	$388.8M
R&D Expenses	$108.3M+11.6%	$97.0M-0.9%	$97.9M+16.4%	$84.1M+7.0%	$78.6M-68.0%	$245.4M-5.1%	$258.7M+27.9%	$202.3M+13.3%	$178.5M-3.4%	$184.8M-4.2%	$192.8M-3.5%	$199.8M+23.2%	$162.2M+55.8%	$104.1M+111.6%	$49.2M
SG&A Expenses	$269.4M+34.1%	$200.9M+18.8%	$169.2M+51.4%	$111.8M-28.2%	$155.7M-61.2%	$400.8M-7.4%	$432.8M+8.0%	$400.7M+19.8%	$334.5M-1.4%	$339.2M-5.4%	$358.7M-14.5%	$419.6M+9.2%	$384.4M-0.8%	$387.6M+72.3%	$225.0M
Operating Income	-$194.7M-661.5%	$34.7Mn/m	-$27.1M-135.3%	$76.8M+866.9%	$7.9Mn/m	-$99.7Mn/m	-$168.4M-1448.8%	$12.5M-81.6%	$67.7M+112.4%	$31.9Mn/m	-$39.2Mn/m	-$127.6M-1061.5%	$13.3M-90.3%	$136.5M+30.6%	$104.6M
EBITDA	-$148.9M-270.6%	$87.3M+0.9%	$86.5M-42.1%	$149.5M+57.2%	$95.1M-3.5%	$98.5M+516.9%	$16.0M-90.6%	$169.8M-16.8%	$204.0M+5.8%	$192.9M+42.8%	$135.1M+163.7%	$51.2M-68.7%	$163.5M-39.2%	$268.9M+90.6%	$141.1M
Interest Expense	$15.0M+184.2%	$5.3M-16.7%	$6.4M-50.8%	$12.9M-62.4%	$34.3M-20.4%	$43.2M-15.2%	$50.9M+35.6%	$37.5M+27.3%	$29.5M-6.1%	$31.4M+7.2%	$29.3M+4.4%	$28.1M+73.3%	$16.2M-22.0%	$20.8M+941.1%	$2.0M
Income Tax	$69.5M+550.6%	$10.7Mn/m	-$43.8M-246.4%	$29.9M+97.8%	$15.1Mn/m	-$43.3Mn/m	-$19.0Mn/m	-$5.5M-1884.5%	$309K-88.2%	$2.6Mn/m	-$1.7Mn/m	-$44.3Mn/m	-$16.3M-137.2%	$43.9M+7.9%	$40.7M
Net Income	-$291.5M-692.8%	$49.2Mn/m	-$86.5M-162.0%	$139.6M-79.9%	$696.1Mn/m	-$182.2M-144.2%	$412.3Mn/m	-$152.6Mn/m	-$25.7Mn/m	-$2.2Mn/m	-$66.5Mn/m	-$104.0Mn/m	-$1.2M-101.6%	$73.6M+17.1%	$62.9M
EPS (Basic)	-$2.70-687.0%	$0.46n/m	-$0.77-172.0%	$1.07-75.5%	$4.37n/m	-$1.10-153.1%	$2.07n/m	-$1.09n/m	-$0.14n/m	-$0.01n/m	-$0.37n/m	-$0.59	-$0.01	$0.39-7.1%	$0.42
EPS (Diluted)	-$2.70-758.5%	$0.41n/m	-$0.77-176.2%	$1.01-76.9%	$4.37n/m	-$1.10-153.1%	$2.07n/m	-$1.09n/m	-$0.14n/m	-$0.01n/m	-$0.37n/m	-$0.59	-$0.01	$0.39-7.1%	$0.42
Diluted Shares (Avg)	108M-13.2%	125M+11.2%	112M-19.2%	139M-12.9%	159M-4.2%	166M-5.5%	176M-2.7%	181M-2.9%	186M+0.6%	185M+2.9%	180M+1.6%	177M	179M	191M+28.7%	148M

Metric	Q4'2410-K	Q3'2410-K	Q2'2410-K	Q1'2410-K	Q4'2310-K	Q3'2310-K	Q2'2310-K	Q1'2310-K
Revenue	$150.1M-2.9%	$145.2M-2.4%	$152.8M-11.8%	$146.4M-2.1%	$154.5M-1.1%	$148.8M+1.6%	$173.2M+16.6%	$149.5M+9.2%
Cost of Revenue	$75.0M+6.0%	$72.8M+3.9%	$72.3M-2.0%	$72.0M+3.2%	$70.8M+2.1%	$70.1M+1.0%	$73.8M+2.7%	$69.7M+1.2%
Gross Profit	$75.0M-10.4%	$72.4M-8.1%	$80.5M-19.0%	$74.4M-6.7%	$83.7M-3.6%	$78.7M+2.3%	$99.4M+29.7%	$79.7M+17.2%
R&D Expenses	$26.4M+12.8%	$27.0M+14.2%	$26.9M+13.4%	$28.0M+6.7%	$23.4M-13.2%	$23.6M-5.7%	$23.8M+2.6%	$26.2M+15.3%
SG&A Expenses	$57.2M-8.6%	$65.7M+27.1%	$69.0M+75.3%	$77.5M+63.7%	$62.6M+43.4%	$51.7M+34.1%	$39.4M-7.0%	$47.3M+5.9%
Operating Income	-$11.4Mn/m	-$23.1M-1956.0%	-$24.2M-171.0%	-$136.1M-3663.8%	-$4.4Mn/m	$1.2Mn/m	$34.0Mn/m	$3.8Mn/m
EBITDA	-$222K-103.2%	-$11.5M-183.6%	-$12.6M-126.2%	-$124.6M-772.2%	$7.0M-88.8%	$13.8M+223.3%	$48.0M+388.0%	$18.5M+75.9%
Interest Expense	$3.3M+169.2%	$3.7M+150.8%	$3.8M+179.3%	$4.2M+244.2%	$1.2M+13.8%	$1.5M+17.3%	$1.4M-27.7%	$1.2M-42.3%
Income Tax	$91.3Mn/m	-$2.9M-179.0%	-$1.9M-119.0%	-$17.0M-579.2%	-$6.7M-137.5%	$3.7Mn/m	$10.1Mn/m	$3.5Mn/m
Net Income	-$113.6M	-$24.4M	-$24.7M	-$128.9M	N/A	N/A	N/A	N/A
EPS (Basic)	-$1.05-1850.0%	-$0.23-253.3%	-$0.23-200.0%	-$1.19-6050.0%	$0.06n/m	$0.15n/m	$0.23n/m	$0.02-90.0%
EPS (Diluted)	-$1.05-2725.0%	-$0.23-264.3%	-$0.23-209.5%	-$1.19-6050.0%	$0.04n/m	$0.14n/m	$0.21n/m	$0.02-88.2%

Not reported in any period shown, so not listed: Diluted Shares (Avg).

MDRX Balance Sheet

MDRX quarterly balance sheet

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Total Assets	$1.4B-14.0%	$1.6B+4.5%	$1.5B-34.9%	$2.3B-20.8%	$2.9B-9.0%	$3.2B+0.8%	$3.2B-24.8%	$4.2B+10.4%	$3.8B+42.9%	$2.7B+8.8%	$2.5B-5.9%	$2.6B+11.5%	$2.3B-6.2%	$2.5B+128.7%	$1.1B
Current Assets	$545.6M-22.0%	$699.2M+2.9%	$679.6M+4.7%	$649.2M-43.7%	$1.2B+37.1%	$841.3M-2.1%	$859.0M+0.2%	$857.1M+41.8%	$604.3M+12.3%	$538.3M+10.5%	$487.2M-9.7%	$539.8M-5.7%	$572.6M-13.0%	$657.8M+61.2%	$408.2M
Cash & Equivalents	$294.3M-34.1%	$446.6M0.0%	$446.6M+234.1%	$133.7M-74.8%	$531.1M+309.6%	$129.7M-25.6%	$174.2M+45.8%	$119.5M+25.0%	$95.6M-18.2%	$116.9M+119.8%	$53.2M-15.5%	$63.0M-39.4%	$104.0M-34.1%	$157.8M+28.1%	$123.1M
Short-Term Investments	$3.7M-87.9%	$30.3Mn/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$2.1M-35.3%	$3.2M
Accounts Receivable	$107.6M-3.2%	$111.2M-6.7%	$119.1M-0.5%	$119.7M-65.5%	$347.4M-18.2%	$424.4M-8.8%	$465.3M-5.5%	$492.6M+21.6%	$405.2M+23.6%	$327.9M-1.1%	$331.6M+5.8%	$313.5M+3.8%	$302.1M-16.7%	$362.8M+99.4%	$181.9M
Long-Term Investments	$98.7M+0.3%	$98.5Mn/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0-100.0%	$149.1Mn/m	$0-100.0%	$1.3M-1.8%	$1.3M-22.1%	$1.7M+1.9%	$1.7M-13.0%	$1.9M
Goodwill	$520.7M-2.2%	$532.5M0.0%	$532.6M+6.9%	$498.4M-0.1%	$498.6M-48.8%	$974.1M-1.2%	$985.8M-23.7%	$1.3B+3.5%	$1.2B+2.1%	$1.2B+1.8%	$1.2B+0.9%	$1.2B+14.5%	$1.0B0.0%	$1.0B+151.4%	$413.4M
Total Liabilities	$548.3M+10.0%	$498.4M+2.3%	$487.2M-78.9%	$2.3B+84.9%	$1.3B-34.8%	$1.9B+20.0%	$1.6B-39.3%	$2.6B+21.5%	$2.2B+71.9%	$1.3B+7.0%	$1.2B-9.3%	$1.3B+22.2%	$1.1B+3.7%	$1.0B+256.7%	$287.9M
Current Liabilities	$421.9M-5.4%	$446.0M+93.6%	$230.3M-52.8%	$488.4M-47.7%	$934.8M-22.8%	$1.2B+51.8%	$797.7M-10.3%	$889.6M+33.4%	$667.1M+30.0%	$513.0M-1.6%	$521.4M+0.8%	$517.0M-0.2%	$518.1M+4.2%	$497.0M+134.4%	$212.1M
Non-Current Liabilities	$126.4M+141.0%	$52.5M-79.6%	$256.9M-85.9%	$1.8B+476.6%	$316.6M-55.4%	$709.9M-11.6%	$803.3M-54.1%	$1.7B+16.3%	$1.5B+100.6%	$749.9M+13.8%	$658.7M-16.0%	$784.5M+43.4%	$547.1M+3.2%	$529.9M+599.3%	$75.8M
Long-Term Debt	$72.2M	N/A	$200.4M-42.8%	$350.1M+108.9%	$167.6M-69.6%	$551.0M-14.9%	$647.5M-28.6%	$906.7M+26.3%	$717.9M+17.2%	$612.4M+13.6%	$539.2M-1.1%	$545.1M+50.3%	$362.7M+12.4%	$322.7M	N/A
Total Equity	$804.0M-25.2%	$1.1B+5.6%	$1.0Bn/m	-$2.8M-100.2%	$1.7B+29.6%	$1.3B-17.1%	$1.6B+38.4%	$1.1B-9.1%	$1.2B-12.5%	$1.4B+9.6%	$1.3B-2.6%	$1.3B+2.6%	$1.3B-13.0%	$1.5B+83.0%	$806.8M
Retained Earnings	$403.4M-41.9%	$695.0M+7.6%	$645.8M-10.3%	$719.8M+13.7%	$633.1Mn/m	-$49.3M-137.1%	$132.8Mn/m	-$338.1Mn/m	-$187.4Mn/m	-$190.2Mn/m	-$188.0Mn/m	-$121.6Mn/m	-$17.5Mn/m	-$16.4Mn/m	-$84.4M

Metric	Q4'2410-K	Q3'2410-K	Q2'2410-K	Q1'2410-K	Q4'2310-K	Q3'2310-K	Q2'2310-K	Q1'2310-K
Total Assets	$1.4B-14.0%	$1.5B-7.3%	$1.5B-4.4%	$1.5B-1.7%	$1.6B+4.5%	$1.6B-6.7%	$1.6B-9.1%	$1.5B-36.6%
Current Assets	$545.6M-22.0%	$556.9M-22.2%	$586.7M-17.6%	$606.8M-12.8%	$699.2M+2.9%	$716.0M-11.7%	$711.7M-14.1%	$695.6M-54.9%
Cash & Equivalents	$294.3M-34.1%	$302.3M-33.7%	$330.7M-29.8%	$343.5M-24.3%	$446.6M0.0%	$455.7M-7.5%	$471.2M-5.8%	$453.9M+448.4%
Short-Term Investments	$3.7M-87.9%	$0n/m	$0n/m	$0n/m	$30.3Mn/m	$0n/m	$0n/m	$0n/m
Accounts Receivable	$107.6M-3.2%	$114.2M-3.3%	$121.0M+3.8%	$110.9M-3.5%	$111.2M-6.7%	$118.1M-30.1%	$116.6M-30.1%	$114.9M-32.6%
Long-Term Investments	$98.7M+0.3%	$104.9M+33.2%	$100.5M+104.0%	$100.1M+103.1%	$98.5Mn/m	$78.7Mn/m	$49.3Mn/m	$49.3Mn/m
Goodwill	$520.7M-2.2%	$520.7M-2.2%	$520.7M-2.2%	$520.7M-2.2%	$532.5M0.0%	$532.5M+1.6%	$532.5M+1.6%	$532.5M+2.4%
Total Liabilities	$548.3M+10.0%	$550.0M+7.5%	$561.5M+10.0%	$565.6M+9.2%	$498.4M+2.3%	$511.4M-0.4%	$510.7M-1.4%	$518.2M-51.9%
Current Liabilities	$421.9M-5.4%	$421.0M-7.2%	$427.2M-5.5%	$502.1M+9.4%	$446.0M+93.6%	$453.9M+79.3%	$452.2M+76.4%	$459.1M-29.0%
Non-Current Liabilities	$126.4M+141.0%	$129.0M+124.1%	$134.3M+129.6%	$63.6M+7.7%	$52.5M-79.6%	$57.6M-77.9%	$58.5M-77.6%	$59.0M-86.3%
Long-Term Debt	$72.2Mn/m	$72.2M	$72.2M	$0	$0-100.0%	N/A	N/A	N/A
Total Equity	$804.0M-25.2%	$911.3M-14.5%	$929.2M-11.3%	$950.0M-7.1%	$1.1B+5.6%	$1.1B-9.5%	$1.0B-12.4%	$1.0B-24.4%
Retained Earnings	$403.4M-41.9%	$517.1M-25.0%	$541.4M-19.5%	$566.1M-12.6%	$695.0M+7.6%	$689.0M-8.5%	$672.5M-9.0%	$647.5M-19.4%

Not reported in any period shown, so not listed: Inventory.

MDRX Cash Flow Statement

MDRX quarterly cash flow statement

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Operating Cash Flow	-$20.0M-120.1%	$99.5M-14.8%	$116.8Mn/m	-$76.6Mn/m	-$103.7M-324.1%	$46.3M-31.9%	$67.9M-75.7%	$279.4M+3.9%	$269.0M+27.1%	$211.6M+104.4%	$103.5M+27.8%	$81.0M-63.6%	$222.7M-17.1%	$268.8M+92.1%	$139.9M
Depreciation & Amortization	$45.8M-13.0%	$52.6M-53.7%	$113.6M+56.1%	$72.8M-16.5%	$87.2M-56.0%	$198.2M+7.5%	$184.4M+17.2%	$157.3M+15.4%	$136.3M-15.3%	$161.0M-7.6%	$174.3M-2.5%	$178.8M+19.0%	$150.2M+13.5%	$132.4M+262.5%	$36.5M
Stock-Based Compensation	$24.5M+50.9%	$16.2M-35.3%	$25.1M+112.7%	$11.8M+10.2%	$10.7M-72.5%	$39.0M+12.5%	$34.6M-5.2%	$36.5M-1.5%	$37.1M+7.0%	$34.7M-11.7%	$39.3M+6.1%	$37.0M-5.4%	$39.1M-4.0%	$40.8M+174.4%	$14.8M
Capital Expenditures	$1.6M-28.9%	$2.2M+5.8%	$2.1M+8.9%	$1.9M-54.5%	$4.2M-74.7%	$16.4M-45.8%	$30.3M-21.7%	$38.8M+20.7%	$32.1M+75.2%	$18.3M-30.7%	$26.4M-64.3%	$74.1M-7.5%	$80.2M+80.9%	$44.3M+218.3%	$13.9M
Free Cash Flow	-$21.6M-122.2%	$97.3M-15.2%	$114.8Mn/m	-$78.5Mn/m	-$107.8M-461.8%	$29.8M-20.6%	$37.5M-84.4%	$240.7M+1.6%	$236.9M+22.6%	$193.3M+150.8%	$77.1M+1023.8%	$6.9M-95.2%	$142.5M-36.5%	$224.4M+78.1%	$126.0M
Investing Cash Flow	-$125.7Mn/m	-$88.3M-115.1%	$585.1Mn/m	-$12.7M-100.8%	$1.6Bn/m	-$161.1M-164.9%	$248.0Mn/m	-$413.0Mn/m	-$1.2Bn/m	-$289.0M	N/A	-$252.1Mn/m	-$123.0Mn/m	-$95.7Mn/m	-$32.0M
Financing Cash Flow	-$6.7Mn/m	-$12.5Mn/m	-$446.2Mn/m	-$258.9Mn/m	-$1.1B-1745.7%	$67.3Mn/m	-$293.0M-247.5%	$198.6M-77.0%	$865.3M+508.2%	$142.3M	N/A	$131.9Mn/m	-$154.9Mn/m	-$143.6Mn/m	-$35.7M
Share Buybacks	$0n/m	$0-100.0%	$234.4M-43.8%	$417.4M+24.9%	$334.1M+199.8%	$111.5M-19.8%	$138.9M+1050.4%	$12.1M-90.0%	$121.2Mn/m	$0n/m	$0n/m	$0-100.0%	$226.0M+339.1%	$51.5Mn/m	$0

Metric	Q4'2410-K	Q3'2410-K	Q2'2410-K	Q1'2410-K	Q4'2310-K	Q3'2310-K	Q2'2310-K	Q1'2310-K
Operating Cash Flow	-$2.7M-113.3%	-$11.3M-143.7%	-$20.8M-171.1%	$14.7M-39.6%	$20.0M-5.2%	$26.0M-7.7%	$29.2Mn/m	$24.4M-64.8%
Depreciation & Amortization	$11.2M-1.8%	$11.5M-7.9%	$11.6M-17.5%	$11.5M-21.8%	$11.4M-84.1%	$12.5M-9.3%	$14.0M-2.4%	$14.7M+4.3%
Stock-Based Compensation	N/A	N/A	N/A	$5.8M-7.2%	N/A	N/A	N/A	$6.2M-1.8%
Capital Expenditures	$334K-6.2%	$148K-26.4%	$691K+85.8%	$379K-69.8%	$356K+91.4%	$201K-10.3%	$372K-71.5%	$1.3M+263.2%
Free Cash Flow	-$3.0M-115.3%	-$11.5M-144.6%	-$21.5M-174.4%	$14.4M-37.9%	$19.6M-6.1%	$25.8M-7.7%	$28.8Mn/m	$23.1M-66.4%
Investing Cash Flow	-$5.4Mn/m	-$16.5Mn/m	$10.3Mn/m	-$114.1Mn/m	-$28.2Mn/m	-$38.3Mn/m	-$7.1M-101.1%	-$14.7Mn/m
Financing Cash Flow	-$3Kn/m	-$614Kn/m	-$2.3Mn/m	-$3.8Mn/m	-$894Kn/m	-$3.1Mn/m	-$4.8Mn/m	-$3.6Mn/m

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MDRX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MDRX quarterly financial ratios

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Gross Margin	50.8%-3.7pp	54.6%+2.1pp	52.4%+3.5pp	48.9%+1.4pp	47.5%+10.1pp	37.4%-1.0pp	38.4%+3.4pp	35.0%-3.8pp	38.8%-3.1pp	41.9%+2.3pp	39.6%+0.7pp	38.9%-3.0pp	41.9%-4.1pp	46.1%-9.1pp	55.2%
Operating Margin	-32.8%-38.3pp	5.5%+10.2pp	-4.6%-17.9pp	13.3%+11.9pp	1.4%+7.5pp	-6.1%+4.3pp	-10.4%-11.1pp	0.7%-3.7pp	4.4%+2.1pp	2.3%+5.1pp	-2.8%+6.5pp	-9.3%-10.2pp	0.9%-8.5pp	9.5%-5.4pp	14.8%
Net Margin	-49.0%-56.9pp	7.9%+22.6pp	-14.7%-38.9pp	24.2%	125.2%	-11.2%-36.7pp	25.5%+33.9pp	-8.5%-6.8pp	-1.7%-1.5pp	-0.2%+4.7pp	-4.8%+2.8pp	-7.6%-7.5pp	-0.1%-5.2pp	5.1%-3.8pp	8.9%
Return on Equity	-36.3%-40.8pp	4.6%+13.1pp	-8.5%	N/A	41.8%+56.0pp	-14.2%-40.8pp	26.6%+40.2pp	-13.6%-11.5pp	-2.1%-1.9pp	-0.2%+5.0pp	-5.2%+2.7pp	-7.9%-7.8pp	-0.1%-5.1pp	5.0%-2.8pp	7.8%
Return on Assets	-21.6%-24.7pp	3.1%+8.9pp	-5.8%-11.8pp	6.0%-17.8pp	23.9%+29.5pp	-5.7%-18.6pp	13.0%+16.6pp	-3.6%-2.9pp	-0.7%-0.6pp	-0.1%+2.6pp	-2.7%+1.3pp	-4.0%-3.9pp	-0.1%-3.0pp	2.9%-2.8pp	5.7%
Current Ratio	1.29-0.3x	1.57-1.4x	2.95+1.6x	1.33+0.1x	1.23+0.5x	0.69-0.4x	1.08+0.1x	0.96+0.1x	0.91-0.1x	1.05+0.1x	0.93-0.1x	1.04-0.1x	1.11-0.2x	1.32-0.6x	1.92
Debt-to-Equity	0.09	N/A	0.20	N/A	0.10-0.3x	0.430.0x	0.42-0.4x	0.81+0.2x	0.58+0.1x	0.430.0x	0.420.0x	0.41+0.1x	0.28+0.1x	0.22	N/A
Liabilities-to-Equity	0.68+0.2x	0.460.0x	0.48	N/A	0.75-0.7x	1.49+0.5x	1.03-1.3x	2.35+0.6x	1.76+0.9x	0.900.0x	0.92-0.1x	0.99+0.2x	0.83+0.1x	0.70+0.3x	0.36
Asset Turnover	0.440.0x	0.400.0x	0.39+0.1x	0.25+0.1x	0.19-0.3x	0.510.0x	0.51+0.1x	0.430.0x	0.40-0.1x	0.520.0x	0.560.0x	0.52-0.1x	0.620.0x	0.58-0.1x	0.64
FCF Margin	-3.6%-19.2pp	15.6%-4.0pp	19.5%+33.1pp	-13.6%+5.8pp	-19.4%-21.2pp	1.8%-0.5pp	2.3%-11.0pp	13.3%-2.0pp	15.3%+1.3pp	13.9%+8.3pp	5.6%+5.1pp	0.5%-9.3pp	9.8%-5.7pp	15.5%-2.3pp	17.9%

Metric	Q4'2410-K	Q3'2410-K	Q2'2410-K	Q1'2410-K	Q4'2310-K	Q3'2310-K	Q2'2310-K	Q1'2310-K
Gross Margin	50.0%-4.2pp	49.8%-3.1pp	52.7%-4.7pp	50.8%-2.5pp	54.2%-1.4pp	52.9%+0.3pp	57.4%+5.8pp	53.3%+3.7pp
Operating Margin	-7.6%-4.7pp	-15.9%-16.7pp	-15.8%-35.4pp	-93.0%-95.5pp	-2.9%+3.2pp	0.8%+7.4pp	19.6%+22.7pp	2.5%+5.2pp
Net Margin	-75.7%	-16.8%	-16.1%	-88.1%	N/A	N/A	N/A	N/A
Return on Equity	-14.1%	-2.7%	-2.6%	-13.6%	N/A	N/A	N/A	N/A
Return on Assets	-8.4%	-1.7%	-1.7%	-8.5%	N/A	N/A	N/A	N/A
Current Ratio	1.29-0.3x	1.32-0.3x	1.37-0.2x	1.21-0.3x	1.57-1.4x	1.58-1.6x	1.57-1.7x	1.51-0.9x
Debt-to-Equity	0.09+0.1x	0.08	0.08	0.00	0.00-0.2x	N/A	N/A	N/A
Liabilities-to-Equity	0.68+0.2x	0.60+0.1x	0.60+0.1x	0.60+0.1x	0.460.0x	0.480.0x	0.49+0.1x	0.51-0.3x
Asset Turnover	0.110.0x	0.100.0x	0.100.0x	0.100.0x	0.100.0x	0.090.0x	0.110.0x	0.100.0x
FCF Margin	-2.0%-14.7pp	-7.9%-25.2pp	-14.0%-30.7pp	9.8%-5.7pp	12.7%-0.7pp	17.3%-1.8pp	16.6%+18.6pp	15.5%-34.9pp

Where VERADIGM INC Ranks

Frequently Asked Questions

What is VERADIGM INC's annual revenue?

VERADIGM INC (MDRX) reported $594.4M in total revenue for fiscal year 2024. This represents a -5.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is VERADIGM INC's revenue growing?

VERADIGM INC (MDRX) revenue declined by 5.0% year-over-year, from $626.0M to $594.4M in fiscal year 2024.

Is VERADIGM INC profitable?

No, VERADIGM INC (MDRX) reported a net loss of $291.5M in fiscal year 2024, with a net profit margin of -49.0%.

What is VERADIGM INC's EBITDA?

VERADIGM INC (MDRX) had EBITDA of -$148.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does VERADIGM INC have?

As of fiscal year 2024, VERADIGM INC (MDRX) had $294.3M in cash and equivalents against $72.2M in long-term debt.

What is VERADIGM INC's gross margin?

VERADIGM INC (MDRX) had a gross margin of 50.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is VERADIGM INC's operating margin?

VERADIGM INC (MDRX) had an operating margin of -32.8% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is VERADIGM INC's net profit margin?

VERADIGM INC (MDRX) had a net profit margin of -49.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is VERADIGM INC's return on equity (ROE)?

VERADIGM INC (MDRX) has a return on equity of -36.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is VERADIGM INC's free cash flow?

VERADIGM INC (MDRX) recorded an outflow of $21.6M in free cash flow during fiscal year 2024. This represents a -122.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is VERADIGM INC's operating cash flow?

VERADIGM INC (MDRX) recorded an outflow of $20.0M in operating cash flow during fiscal year 2024, representing cash used by core business activities.

What are VERADIGM INC's total assets?

VERADIGM INC (MDRX) had $1.4B in total assets as of fiscal year 2024, including both current and long-term assets.

What are VERADIGM INC's capital expenditures?

VERADIGM INC (MDRX) invested $1.6M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How much does VERADIGM INC spend on research and development?

VERADIGM INC (MDRX) invested $108.3M in research and development during fiscal year 2024.

How many shares does VERADIGM INC have outstanding?

VERADIGM INC (MDRX) had 108M shares outstanding as of fiscal year 2024.

What is VERADIGM INC's current ratio?

VERADIGM INC (MDRX) had a current ratio of 1.29 as of fiscal year 2024, which is considered adequate.

What is VERADIGM INC's debt-to-equity ratio?

VERADIGM INC (MDRX) had a debt-to-equity ratio of 0.09 as of fiscal year 2024. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is VERADIGM INC's liabilities-to-equity ratio?

VERADIGM INC (MDRX) had a liabilities-to-equity ratio of 0.68 as of fiscal year 2024, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is VERADIGM INC's return on assets (ROA)?

VERADIGM INC (MDRX) had a return on assets of -21.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is VERADIGM INC's P/E ratio?

VERADIGM INC (MDRX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2024). The market capitalization is $517.7M as of Oct 27, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is VERADIGM INC's price-to-sales ratio?

VERADIGM INC (MDRX) trades at 0.9x sales, its market capitalization divided by $594.4M revenue, FY2024. The market capitalization is $517.7M as of Oct 27, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is VERADIGM INC's Altman Z-Score?

VERADIGM INC (MDRX) has an Altman Z-Score of 1.06, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is VERADIGM INC's Piotroski F-Score?

VERADIGM INC (MDRX) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are VERADIGM INC's earnings high quality?

VERADIGM INC (MDRX) reported a net loss of $291.5M while operations used $20.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can VERADIGM INC cover its interest payments?

VERADIGM INC (MDRX) reported an operating loss of $194.7M against $15.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.